TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/26/23 18:18 | 9/22/23 | MNTS | Momentus Inc. | DE | Aero | Aero | Guided Missiles & Space Vehic | Prime Movers Lab Fund I LP | WY | T | S.m | -226 | 2.08 | 0 | -108 | -51 | 106 | M | |||||||||||||||
9/14/23 18:17 | 9/12/23 | MNTS | Momentus Inc. | DE | Aero | Aero | Guided Missiles & Space Vehic | Prime Movers Lab Fund I LP | WY | T | S.m | -632 | 3.59 | 0 | -176 | -45 | 214 | M | |||||||||||||||
9/11/23 18:05 | 9/7/23 | MNTS | Momentus Inc. | DE | Aero | Aero | Guided Missiles & Space Vehic | Prime Movers Lab Fund I LP | WY | T | S.m | -241 | 6.13 | 0 | -39 | -9 | 390 | M | |||||||||||||||
9/8/23 18:05 | 9/6/23 | VAXX | Vaxxinity, Inc. | FL | Health | Drug | Pharmaceutical Preparations | Prime Movers Lab Fund I LP | WY | T | S.m | -169 | 1.74 | 0 | -97 | -1 | 16,657 | M | |||||||||||||||
6/9/23 16:14 | 6/7/23 | MNTS | Momentus Inc. | DE | Aero | Aero | Guided Missiles & Space Vehic | Prime Movers Lab Fund I LP | WY | T | S.m | -1,123 | 0.2808 | 0 | -4,000 | -16 | 21,472 | M | |||||||||||||||
1/25/23 17:58 | 1/23/23 | VAXX | Vaxxinity, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Prime Movers Lab Fund I LP | WY | T | S | -1,678 | 3.35 | 0 | -501 | -3 | 16,754 | M |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |